Wells Fargo & Company »

Vyne Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $534 174 3.07
2023-12-31 $399 172 2.32
2023-09-30 $424 105 4.04
2023-06-30 $365 89 4.11